The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 24, Issue 9, 2002, Pages 565-571

  Stefek, M ^a,c   Gajdosik, A ^a   Tribulova, N ^b   Navarova, J ^a   Volkovova, K ^a   Weismann, P ^a   Gajdosikova, A ^a   Drimal, J ^a   Mihalova, D ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Albuminuria; Antioxidant; Diabetic nephropathy; Oxidative stress; Stobadine; Streptozotocin

Indexed keywords

ANTIOXIDANT; CARBOLINE DERIVATIVE; COLLAGEN; STOBADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; ENZYMURIA; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY FUNCTION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN GLYCOSYLATION; PROTEINURIA; RAT; RISK BENEFIT ANALYSIS; STREPTOZOCIN DIABETES;

ACETYLGLUCOSAMINIDASE; ALBUMINURIA; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CARBOLINES; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; LIPID PEROXIDATION; MALE; ORGAN SIZE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 0036873473     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Lehmann, R., Schleicher, E.D. Molecular mechanism of diabetic nephropathy. Clin Chim Acta 2000, 297: 135-44.
2. Baynes, J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40: 405- 12.
3. Baynes, J.W., Thorpe, S.R. Perspectives in diabetes. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 1999, 48: 1-9.
4. Ceriello, A. Oxidative stress and glycemic regulation. Metab Clin Exp 2000, 49 (Suppl. 1): 27-9.
5. Suzuki, D., Miyata, T., Saotome, N. et al. Immunohistochemical evidence for an increased oxidative stress and carbolzyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 1999, 10: 822-32.
6. Miyata, T., Wada, Y., Cai, Z. et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997, 51: 1170-81.
7. Larkins, R.G., Dunlop, M.E. The link between hyperglycemia and diabetic nephropathy. Diabetologia 1992, 35: 499-504.
8. Ha, H., Yu, M-R., Kim, K.H. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 1999, 26: 944-50.
9. Koya, D., Lee, I-K., Ishi, H., Kanoh, H.G.L., King, G.L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-átocopherol. J Am Soc Nephrol 1997, 8: 426-35.
10. Soulis-Liparota, T., Cooper, M.E., Dunlop, M., Jerums, G. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 1995, 38: 387-94.
11. Trachtman, H., Futterweit, S., Maesaka, J. et al. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am J Physiol 1995, 269: F429-38.
12. Stefek, M., Sotnikova, R., Okruhlicova, L. et al. Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol 2000, 37: 111-7
13. Sotnikova, R., Stefek, M., Okruhlicova, L. et al. Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocin-diabetic rats. Methods Find Exp Clin Pharmacol 2001, 23: 121-9.
14. Peterson, G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Analyt Biochem 1977, 83: 346-56.
15. Barrett, A.J., Heath, M.F. Lysosomal enzymes. In: Dingle, J.T. (Ed.). Lysosomes. Elsevier/ North-Holland Biomedical Press 1977: 19-29.
16. Recknagel, L., Glende, E.A. Spectrophotometric determination of lipid conjugated dienes. Meth Enzymol 1984, 105: 331-7.
17. Knicht, J.A., Anderson, S., Rawle, J.M. Chemical basis of the sulfophospho-vanilin reaction for estimation total serum lipids. Clin Chem 1972, 18: 199-204.
18. Harrison, D.E., Archer, J.R. Measurement of changes in mouse tail collagen with age: Temperature dependence and procedural details. Exp Geront 1978, 13: 75-82.
19. Vijayalingam, S., Perthiban, A., Shanmugasundaram, K.R., Mohan, V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med 1996, 13: 715-9
20. Ashour, M., Salem, S., Hassaneen, H. et al. Antioxidant status and insulin-dependent diabetes mellitus (IDDM). J Clin Biochem Nutr 1999, 26: 99-107.
21. Brownlee, M. Negative consequences of glycation. Metab Clin Exp 2000, 49 (Suppl. 1): 9-13.
22. Ohkuwa, T., Sato, Y., Naoi, M. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 1995, 56: 1789-98.
23. Sundaram, R.K., Bhaskar, A., Vijayalingam, S. Antioxidant status and lipid peroxidation in type H diabetes mellitus with and without complications. Clin Sci 1996, 90: 255-60.
24. Perthiban, A., Shanmugasundaram, K.R., Mohan, V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med 1996, 13: 715-9.
25. Jung, K., Mattenheimer, H., Burchardt, U. Urinary enzymes. Springer Verlag: Berlin, 1991.
26. Viberti, G.C., Walker, J.D., Pinto, J. Diabetic nephropathy. In: International Textbook of Diabetes Mellitus. Alberti, K.G.M.M., DeFronzo, R.A., Keen, H., Zimmet, P. (Eds.). Vol. 2. John Willey & Sons, 1992: 1267-1328.
27. Mattenheimeir, H. Enzymes and renal diseases. Ann Clin Lab Sci 1977, 7: 422-32.
28. Price, R.G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982, 23: 99-134.
29. Watts, G.F., Vlitos, M.A.J., Morris, R.W., Price, R.G. Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent dia betes mellitus: Relation to microalbuminuria, retinopathy and glycaemic control. Diabete & Metabolisme 1988, 14: G653-8.
30. Piscator, M. Markers of tubular dysfunction. Toxicol Lett 1989, 46: 197-204.
31. Stefek, M., Masarykova, M., Benes, L. Inhibition of cumene hydroperoxide-induced lipid peroxidation by a novel pyridoindole antioxidant in rat liver microsomes. Pharmacol Toxicol 1992, 70: 407-11.
32. Stefek, M., Trnkova, Z. The pyridoindole antioxidant stobadine prevents alloxan-induced lipid peroxidation by inhibiting its propagation. Pharmacol Toxicol 1996, 78: 77-81.
33. Horakova, L., Briviba, K.H., Sies, H. Antioxidant activity of the pyridoindole stobadine in liposomal and microsomal lipid peroxidation. Chem-Biol Interactions 1992, 83: 85-93.
34. Kaplan, P., Doval, M., Majerova, Z., Lehotsky, J., Racay, P. Iron-induced lipid peroxidation and protein modification in endoplasmic reticulum membranes. Protection by stobadine. Int J Biochem Cell Biol 2000, 32: 539-47.
35. Horakova. L, Uraz, V., Ondrejickova, O., Lukovic, L., Juranek, I. Effect of stobadine on brain lipid peroxidation induced by incomplete ischemia and subsequent reperfusion. Biomed Biochim Acta 1991, 8: 1019-25.
36. Horakova, L., Onderjickova, O., Uraz, V., Lukovic, L., Juranek, I. Short celebral ischemia and reperfusion and treatment with stobadine. Experientia 1992, 48: 872-4.
37. Stefek, M., Krizanova, L., Trnkova, Z. Oxidative modification of serum albumin in an experimental glycation model of diabetes mellitus in vitro: Effect of the pyridoindole antioxidant stobadine. Life Sci 1999, 65: 1995-7.
38. Maxwell, S.R., Thomason, H., Sandler, D. et al. Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus. Ann Clin Biochem 1997, 34: 638-44.
39. Williamson, J.R., Kilo, C. Basement membrane physiology and pathophysiology. In: International Textbook of Diabetes Mellitus. Alberti, K.G.M.M., DeFronzo, R.A., Keen, H., Zimmet, P. (Eds.). Vol. 2. John Willey & Sons, 1992: 1245-65.
40. Monnier, V.W., Glomb, M., Elgawish, A., Sell, D.R. The mechanism of collagen cross-linking in diabetes. A puzzle nearing resolution. Diabetes 1996, 45 (Suppl. 3): S67-72.
41. Paul, R.G., Bailey, J. Glycation of collagen: The basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol 1996, 28: 1297-310.
42. Monnier, V.W., Bautista, O., Kenny, D. et al. Skin collagen glycation, glycoxidation, and cross-linking are lower in subjects with long-term intensive versus conventional therapy of type I diabetes. Diabetes 1999, 48: 870-80.
43. Beisswenger, P., Makita, Z., Curphey, T.J. et al. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestation of renal and retinal disease in diabetes. Diabetes 1995, 44: 824-9.
44. Warram, J.H., Scott, L.J., Hanna, L.S. et al. Progression of microalbuminuria to proteinuria in type I diabetes. Diabetes 2000, 49: 94-100.
45. Guder, W.G., Ivandic, M., Hofman, W. Physiopathology of proteinuiria and laboratory diagnostic strategy based on single protein analysis. Clin Chem Lab Med 1998, 36: 935-9.
46. Cooper, M.E., Jerums, G., Allen, T.J., Macmillan, P.A., Doyle, A.E. Hypertension and experimental diabetes: Conventional antihypertensive therapy versus angiotensin converting enzyme inhibition. J Hypertension 1989, 7 (Suppl. 6): S35-6.
47. Anderson, S., Rennke, H.G., Garcia, D.L., Brenner, B.H. Short and long term effects of anti-hypertensive therapy in the diabetic rat. Kidney Int 1989, 36: 526-36.
48. Parving, H-H., Andersen, A.R., Smidt, U.M., Hommel, E., Mathiesen, E.R., Svendsen, P.R. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987, 294: 1444-7.
49. Kittova, M., Gibala, P., Drimal, J. Antiarrhytmic and hemodynamic effects of pyridoindole derivative (DH 1011) in experimental models of heart rhythm and function disturbances. Bratisl Lek Listy 1985, 84: 542-56.
50. Sotnikova, R., Gibala, P., Drimal, J. Effect of substance DH 1011 on vascular smooth muscle. Bratisl Lek Listy 1985, 84: 273-8.
51. Sotnikova, R., Gibala, P., Drimal, J. Alpha-adrenolytic activity of the substance DH 1011. Bratisl Lek Listy 1985, 84: 536-41.